York Pharma PLC
P O Box 48
Hitchin
Hertfordshire
SG5 3ZH
United Kingdom
Tel: +44-0)-870-066-4453
Website: http://www.yorkpharma.com/
Email: info@yorkpharma.com
14 articles about York Pharma PLC
-
ULURU Inc. Discussions to Acquire York Pharma PLC Terminated
6/25/2009
-
ULURU Inc. Signs Offer Letter to Acquire York Pharma PLC
4/7/2009
-
York Pharma PLC: Market Update
2/3/2009
-
York Pharma PLC Receives A Translation Award Of £100,014 From The Wellcome Trust For The Development Of A Specialist Wound Care Product
12/16/2008
-
York Pharma PLC Acquires Two Marketed Specialist Wound Care Products from Celltran Limited and £510,000 Institutional Placing
10/28/2008
-
York Pharma PLC Announces The Acquisition Of Leading Dermatological & Wound Care Brands; Company has Raised $51.2 Million to Finance the Product Acquisition and Support Future Operations
10/3/2008
-
York Pharma PLC Release: Acquisition of Leading Dermatological & Wound Care Brands, $48 Million (£24.2 Million) Financing and £3.9 Million Institutional Placing
7/8/2008
-
York Pharma PLC Release: New Abasol™ Formulation for Onychomycosis can Effectively and Rapidly Penetrate the Nail Barrier
10/31/2007
-
York Pharma PLC Release: Pre-IND Conference Requested to Enable International Phase IIb Study for Sabarep™
10/22/2007
-
York Pharma PLC Acquires Derms Development for 17.5 Million stg
10/9/2007
-
York Pharma PLC H1 Pretax Loss Widens, Buys Rosanto for 2 Million stg
4/24/2007
-
York Pharma PLC Delays Launch Of Lead Product Abasol To 2007 After Regulator Query
10/4/2006
-
York Pharma PLC H1 Loss Widens In Line With Expectations
5/3/2006
-
York Pharma PLC Files New Patent For Skin Disease, Cancer Treatment
3/20/2006